Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study

AIM: To confirm the efficacy and safety of bevacizumab/XELOX combination for the treatment of locally advanced or metastatic colorectal cancer (CRC) in Italy. METHODS: This multicentric, prospective, open-label study included patients with CRC previously untreated with chemotherapy. Patients were ad...

全面介紹

Na minha lista:
書目詳細資料
發表在:World J Gastroenterol
Main Authors: Antonuzzo, Lorenzo, Giommoni, Elisa, Pastorelli, Davide, Latiano, Tiziana, Pavese, Ida, Azzarello, Domenico, Aieta, Michele, Pastina, Ilaria, Di Fabio, Francesca, Bertolini, Alessandro, Corsi, Domenico Cristiano, Mogavero, Selene, Angelini, Valentina, Pazzagli, Mario, Di Costanzo, Francesco
格式: Artigo
語言:Inglês
出版: Baishideng Publishing Group Inc 2015
主題:
Prospective Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4476891/
https://ncbi.nlm.nih.gov/pubmed/26109816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i23.7281
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍